# EDGAR Filing Document

**Accession Number:** 0002127064
**File Stem:** 0000097476-26-000092
**Filing Date:** 2026-4
**Character Count:** 7943
**Document Hash:** 5ee0af6db0eae2b2b03a0ec014cf2aca
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000097476-26-000092.hdr.sgml**: 20260406

**ACCESSION NUMBER**: 0000097476-26-000092

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260325

**FILED AS OF DATE**: 20260406

**DATE AS OF CHANGE**: 20260406

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Abraham Tsedeniya
- **CENTRAL INDEX KEY:** 0002127064

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-03761
- **FILM NUMBER:** 26840671

**MAIL ADDRESS:**
- **STREET 1:** 12500 TI BOULEVARD
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75243
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TEXAS INSTRUMENTS INC
- **CENTRAL INDEX KEY:** 0000097476
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 750289970
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** P.O. BOX 660199
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75266
- **BUSINESS PHONE:** 9729953773

**MAIL ADDRESS:**
- **STREET 1:** 12500 TI BLVD
- **STREET 2:** PO BOX 660199
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75266

## Ex-24

![](poa_abraham001.jpg)

Docusign Envelope ID: 74664452-8500-423F-A8DC-42A88CB33FF7 AUTHORIZATION I hereby authorize Katharine Kane, Shannon S. Thompson, Elizabeth M. Bedell, Tonya Moran, Joseph S. Jablonski, Erin E. Hilton and John Whitney or any one of them to sign and file on my behalf any and all forms required by the Securities and Exchange Commission pursuant to Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") relating to the reporting of beneficial ownership of equity securities of Texas Instruments Incorporated (the "Company"), and of changes in such beneficial ownership, as well as any and all representation letters that may be required in connection with sales by me of equity securities of the Company, together with any and all amendments to the foregoing. This authorization shall be effective on and after the date set forth below and shall continue in effect, unless earlier revoked by me in writing, until I am no longer required to file such forms and letters provided, however, that this authorization shall be deemed revoked with respect to any individual named above upon such individual's termination of active service with the Company. On and after the date set forth below, any authorization previously granted by me concerning the subject matter hereof is revoked. I acknowledge that the persons authorized hereunder are not assuming, nor is the Company assuming, any of my responsibilities to comply with Section 16 of the Exchange Act and other relevant securities laws. Dated as of 23rd day of March 2026. Tsedeniya Abraham

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Abraham Tsedeniya<br><sub>(Last) (First) (Middle)</sub><br>12500 TI BOULEVARD<br><sub>(Street)</sub><br>DALLAS, TX 75243<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>TEXAS INSTRUMENTS INC [ TXN ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-25 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Sr. Vice President_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 21562<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| NQ Stock Option (Right to Buy) | <sup>(2)</sup> | 2027-01-26 | Common Stock | 1365 | $79.26 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(3)</sup> | 2028-01-25 | Common Stock | 1508 | $110.15 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(4)</sup> | 2029-01-25 | Common Stock | 2833 | $104.41 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(5)</sup> | 2030-01-24 | Common Stock | 5867 | $130.52 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(6)</sup> | 2031-01-28 | Common Stock | 4915 | $169.23 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(7)</sup> | 2032-01-27 | Common Stock | 7537 | $174.81 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(8)</sup> | 2033-01-26 | Common Stock | 8098 | $174.10 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(9)</sup> | 2034-01-25 | Common Stock | 10000 | $167.42 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(10)</sup> | 2035-01-27 | Common Stock | 8320 | $187.03 | D |  |
| NQ Stock Option (Right to Buy) | <sup>(11)</sup> | 2036-01-29 | Common Stock | 9707 | $218.97 | D |  |

---

### Footnotes:

(1) Includes 9,141 shares subject to terms of restricted stock units awarded under the Issuer's long-term incentive plans.

(2) The stock option became exercisable in four equal annual installments beginning on January 26, 2018.

(3) The stock option became exercisable in four equal annual installments beginning on January 25, 2019.

(4) The stock option became exercisable in four equal annual installments beginning on January 25, 2020.

(5) The stock option became exercisable in four equal annual installments beginning on January 24, 2021.

(6) The stock option became exercisable in four equal annual installments beginning on January 28, 2022.

(7) The stock option became exercisable in four equal annual installments beginning on January 27, 2023.

(8) The stock option became exercisable in four equal annual installments beginning on January 26, 2024.

(9) The stock option became exercisable in four equal annual installments beginning on January 25, 2025.

(10) The stock option became exercisable in four equal annual installments beginning on January 27, 2026.

(11) The stock option becomes exercisable in four equal installments beginning on January 29, 2027.

**Signature:** /s/ Shannon Thompson, Attorney in Fact  
**Date:** 2026-04-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**